This Senate resolution designates the first week of August 2026 as "National Community Health Center Week" to recognize the role these facilities play in providing affordable primary care across the United States. The bill highlights that community health centers serve a diverse range of populations, including those in rural and urban areas, by offering integrated services such as mental health, dental, and pharmacy care. It encourages the general public to participate in the observance by visiting local centers and celebrating the partnership between these organizations and their communities.
The FORMULA Act of 2026 requires the U.S. Food and Drug Administration to set strict limits on contaminants in infant formula, including heavy metals, microplastics, and synthetic pesticides. Manufacturers must test their products to meet these new standards and keep records of their testing for at least two years after the formula's shelf life expires. The law also mandates that the FDA report annually to Congress on any violations and the progress made in reducing contaminant levels in the domestic supply chain. These regulations will take effect 180 days after the bill is signed into law.
This resolution designates July 15, 2026, as Glioblastoma Awareness Day to raise public attention about this aggressive and deadly form of brain cancer. The bill honors patients and families affected by the disease while encouraging greater awareness of the urgent medical needs and research opportunities surrounding it. It also expresses support for collaborative efforts among government, private, and nonprofit organizations to develop better treatments and invests in ongoing research initiatives.
This Senate resolution formally supports the goals and ideals of National Nurses Week, which is observed annually from May 6 to May 12, 2026. The measure recognizes the vital contributions of nurses to the healthcare system and encourages the public to acknowledge their role through ceremonies and activities during the designated week. While the bill does not create new laws or funding, it serves to honor the profession and highlight the importance of nursing in patient care and public health.
The Ensuring Access to General Surgery Act of 2026 directs the Health Resources and Services Administration to conduct a comprehensive study on how to better identify areas underserved by general surgeons. This study will evaluate current shortage designations and test a new methodology that maps hospital services against patient populations to determine if there are enough surgeons to meet local needs. Following the study, the agency may create a formal system to designate specific general surgery shortage areas, which would be updated annually based on data regarding wait times, health outcomes, and geographic access. The bill requires the government to consult with medical professionals and patient groups throughout this process and to publish regular data reports on the availability of surgical care across urban, suburban, and rural regions.
This bill, titled the Nursing is a Professional Degree Act, updates federal definitions to classify nursing degrees as professional degrees. It directly affects students pursuing nursing education and the federal financial aid programs that support them. The legislation amends the Higher Education Act to explicitly list nursing degrees, such as the Master of Science in Nursing and Doctor of Nursing Practice, alongside other advanced fields like medicine and law. By making this change, the bill ensures that nursing programs are recognized at the same level as other established professional disciplines within the federal student aid system.
This bill, titled the Nursing is a Professional Degree Act, updates federal definitions to classify nursing degrees at the master's or doctoral level as professional degrees. By amending the Higher Education Act, it explicitly lists nursing programs such as the Master of Science in Nursing (MSN) and Doctor of Nursing Practice (DNP) alongside other established professions like medicine and law. This change requires nursing degrees to meet specific criteria, including completion of academic requirements for professional practice and demonstration of skills beyond a standard bachelor's degree. The primary effect is to formally recognize nursing as a professional field within federal higher education regulations, which may influence how nursing programs are funded or categorized.
This Senate resolution formally supports the goals of National Hospital Week, which is observed annually from May 10 to May 16, 2026. The measure recognizes the vital contributions of hospitals and healthcare workers, including physicians, nurses, and support staff, who provide essential services to millions of Americans. It highlights the diverse roles of various hospital types, such as critical access facilities in rural areas, teaching hospitals, psychiatric centers, and VA medical centers. The resolution encourages the public to observe the week with appropriate ceremonies and activities to demonstrate appreciation for the healthcare system.
Ensuring Seniors' Access to Quality Care Act This bill repeals certain restrictions under Medicare and Medicaid that prohibit the approval of nurse-aide training and competency evaluation programs in skilled nursing facilities that have been subject to specified regulatory actions (e.g., civil penalties) for substandard quality of care. The Centers for Medicare & Medicaid Services (CMS) must still disapprove such programs for up to two years; however, the CMS must rescind the disapproval upon completion of corrective action and may require additional oversight of the program for purposes of rescission. The bill also allows Medicaid and Medicare providers (e.g., skilled nursing facilities) to access, through the National Practitioner Data Bank, disciplinary information for affiliated physicians and other health care practitioners, as reported by state licensing authorities.
This bill extends the funding authorization for the Accelerating Access to Critical Therapies for ALS Act from 2026 to 2031, ensuring continued financial support for research into treatments for amyotrophic lateral sclerosis. It requires the Food and Drug Administration to review clinical trial data more rigorously by assessing patient enrollment numbers and requesting interim results from drug manufacturers before renewing research grants. Additionally, the legislation clarifies that clinical trials in phase 3 include combined phase 2/3 studies and planned trials that have not yet started enrolling participants. The bill also mandates the FDA to publish a report within a year of enactment detailing its progress on rare neurodegenerative disease action plans and how it coordinates with broader disease communities. Finally, it adjusts the timeline for a Government Accountability Office report to cover a five-year period instead of four.
